The burden of food related ill health in the UK

November 14, 2005

The UK's poor dietary habits are costing its health service an annual £6 billion - three times as much as the financial toll from smoking - reveals research in the Journal of Epidemiology and Community Health.

The research team used European data from the World Health Organization's burden of disease project, calculating the proportion of ill health and deaths attributable to food. The definition included food poisoning as well as dietary habits.

The information gathered was then backed up by an extensive review of published studies on the financial and health costs of disease and deaths related to food consumption.

The authors used a composite term to describe the impact of ill health and death, known as DALYs, or disability adjusted life years.

They calculated that 37% of DALYS were attributable to food related diseases, with just a fraction of this (0.2%) attributable to food poisoning. Cardiovascular disease, cancer, and diabetes account for most of this.

Clearly, diet is not responsible for all cardiovascular disease, diabetes, and cancer, which account for 28% of health service costs, amounting to an annual £18 billion in 2002.

But the authors calculate that food accounts for around a third, accounting for 10% of all DALYS and costing an annual £6 billion.

This is double the cost to the health service of road traffic accidents, over three times the cost of smoking, and significantly higher than the cost of obesity, estimated at £479 million.

The authors admit their calculations are crude, but suggest that they are probably reasonable. "The estimates suggest that the burden of food related ill health is large, compared with say, smoking, and suggests that [it] has been neglected by health and food policy makers," they say.

And they call for more specific government health targets on diet, equivalent to those already in place for smoking.
-end-


BMJ Specialty Journals

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.